Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer.
Biagio RicciutiArielle ElkriefJoao M Victor AlessiXinan WangYvonne Y LiHersh V GuptaDaniel M MuldoonArrien A BertramFederica PecciGiuseppe LambertiAlessandro Di FedericoAdriana P BarrichelloVictor R VazMalini M GandhiElinton LeeGeoffrey I ShapiroHyesun ParkMizuki NishinoJames R LindsayKristen D FeltBijaya SharmaAndrew D CherniakScott J RodigDaniel R GomezNarek ShaverdianMehrdad RakaeeChaitanya BandlamudiMarc LadanyiPasi A JanneAdam J SchoenfeldLynette M ShollMark M AwadMichael L ChengPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Deleterious ATM mutations defined a subset of NSCLC with unique clinicopathologic, genomic, and immunophenotypic features. Our data may serve as resource to guide interpretation of specific ATM mutations in NSCLC.